Expert Discusses Impact of Immunotherapy, Molecular Testing Advances in NSCLC – Targeted Oncology
Targeted Oncology |
Expert Discusses Impact of Immunotherapy, Molecular Testing Advances in NSCLC
Targeted Oncology In a recent interview with Targeted Oncology, Joel Neal, MD, PhD, assistant professor of Medicine (Oncology), Stanford University Medical Center, discussed how recent immunotherapy advances are transitioning the field of NSCLC and how the impact of … |
